The risk or severity of adverse effects can be increased when Bisoprolol is combined with Hydrochlorothiazide. The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Sulfisoxazole. Methylene blue may increase the hypotensive activities of Bisoprolol. Methylphenobarbital may increase the hypotensive activities of Bisoprolol. PTC299 may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Darifenacin. Vardenafil may increase the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be increased when combined with Primidone. Sildenafil may increase the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Desipramine. Bisoprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate. Etofenamate may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Imatinib. Mesalazine may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Tetrahydropalmatine. Memantine may increase the bradycardic activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Propafenone. The metabolism of Bisoprolol can be decreased when combined with Itraconazole. The metabolism of Bisoprolol can be decreased when combined with Clotrimazole. The serum concentration of Bisoprolol can be decreased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Levosimendan is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Nilotinib. Ketoprofen may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Cicletanine. Propacetamol may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Desflurane is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bisoprolol. Hexobarbital may increase the hypotensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Ritodrine. The risk or severity of adverse effects can be increased when Nitroprusside is combined with Bisoprolol. Edrophonium may increase the bradycardic activities of Bisoprolol. Nialamide may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Proscillaridin. Castanospermine may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Aminophylline. Naphazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Levomilnacipran. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Papaverine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Etacrynic acid. Bisoprolol may decrease the bronchodilatory activities of Olodaterol. Bisoprolol may increase the hypotensive activities of Deserpidine. Guanadrel may increase the hypotensive activities of Bisoprolol. Yohimbine may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Indinavir. Benzydamine may decrease the antihypertensive activities of Bisoprolol. Paliperidone may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Varenicline. Guanabenz may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Mycophenolate mofetil may decrease the antihypertensive activities of Bisoprolol. Rofecoxib may decrease the antihypertensive activities of Bisoprolol. Brimonidine may increase the antihypertensive activities of Bisoprolol. Triptolide may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Silodosin. Bisoprolol may increase the bradycardic activities of Ouabain. The risk or severity of adverse effects can be increased when Benazepril is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Midostaurin. Bisoprolol may increase the hypoglycemic activities of Glimepiride. Bisoprolol may increase the hypotensive activities of Rescinnamine. Selegiline may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acetylcholine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Chlorothiazide. The serum concentration of Bisoprolol can be increased when it is combined with Darunavir. The metabolism of Bisoprolol can be decreased when combined with Eliglustat. The metabolism of Bisoprolol can be increased when combined with Carbamazepine. Sulindac may decrease the antihypertensive activities of Bisoprolol. Perazine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Atomoxetine. Lercanidipine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Manidipine. Pheniprazine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Lovastatin. The risk or severity of adverse effects can be increased when Morphine is combined with Bisoprolol. Bisoprolol may increase the hypotensive activities of Naftopidil. The metabolism of Bisoprolol can be decreased when combined with Venlafaxine. Distigmine may increase the bradycardic activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Formoterol. SRT501 may decrease the antihypertensive activities of Bisoprolol. Cyclothiazide may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Isavuconazonium. The metabolism of Bisoprolol can be decreased when combined with Ranolazine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dinutuximab. Apremilast may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Candoxatril. The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Bisoprolol. Safrazine may increase the hypotensive activities of Bisoprolol. Procarbazine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Trichlormethiazide. Bisoprolol may increase the hypotensive activities of Polythiazide. The metabolism of Bisoprolol can be decreased when combined with Cinacalcet. Bisoprolol may increase the hypotensive activities of Epoprostenol. Bisoprolol may decrease the bronchodilatory activities of Terbutaline. The risk or severity of adverse effects can be increased when Imidapril is combined with Bisoprolol. Antipyrine may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Nitrendipine. Icatibant may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be increased when combined with Phenobarbital. Echothiophate may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Propofol is combined with Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Ivacaftor. Bisoprolol may increase the orthostatic hypotensive activities of Trimazosin. The risk or severity of adverse effects can be increased when Arotinolol is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Citalopram. Bisoprolol may decrease the bronchodilatory activities of Arformoterol. Bisoprolol may increase the hypotensive activities of Theodrenaline. The risk or severity of adverse effects can be increased when Amlodipine is combined with Bisoprolol. Triflupromazine may increase the hypotensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Bambuterol. Pentoxifylline may increase the hypotensive activities of Bisoprolol. Tubocurarine may increase the bradycardic activities of Bisoprolol. Parecoxib may decrease the antihypertensive activities of Bisoprolol. Oxaprozin may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Aliskiren. Remikiren may increase the hypotensive activities of Bisoprolol. Tacrine may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Enalaprilat. The metabolism of Bisoprolol can be decreased when combined with Diphenhydramine. Octreotide may increase the bradycardic activities of Bisoprolol. Droxicam may decrease the antihypertensive activities of Bisoprolol. Duvelisib may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Eplerenone. The metabolism of Bisoprolol can be decreased when combined with Fluoxetine. 1,10-Phenanthroline may increase the bradycardic activities of Bisoprolol. Fluphenazine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Terlipressin. Lornoxicam may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Procaterol. Azapropazone may decrease the antihypertensive activities of Bisoprolol. Felbinac may decrease the antihypertensive activities of Bisoprolol. Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.